Lessons From the Real World: Treating High Risk HR+/HER2- Breast Cancer According to the Latest Evidence episode artwork

EPISODE · Apr 22, 2026 · 32 MIN

Lessons From the Real World: Treating High Risk HR+/HER2- Breast Cancer According to the Latest Evidence

from Keeping Current CME

Risk vs Biology: Which carries more weight in the decision to escalate therapy? Credit available for this activity expires: 04/21/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/lessons-real-world-treating-high-risk-hr-her2-breast-cancer-2026a1000bhd?ecd=bdc_podcast_libsyn_mscpedu

Episode metadata supplied by the publisher feed · Published Apr 22, 2026

Embed this episode

NOW PLAYING

Lessons From the Real World: Treating High Risk HR+/HER2- Breast Cancer According to the Latest Evidence

0:00 32:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 32 minutes long.

When was this Keeping Current CME episode published?

This episode was published on April 22, 2026.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!